When the biological battery runs out
Imagine your cells as a TV remote control or a digital camera: they need energy to function. This energy is produced by tiny internal power plants called mitochondria, which fuel every second of your existence. But just like old AA batteries lying around in the back of a drawer, mitochondria eventually lose their power. This decline in energy is not insignificant; mitochondrial damage can lead to a cascade of health problems, ranging from muscle weakness to vision or hearing loss, and even fainting. However, a scientific breakthrough offers new hope: researchers have developed a method to « recharge » these failing mitochondria, paving the way for potential treatments for age-related symptoms.
« Nanoflower » technology
A study published last December in the journal PNAS by Texas A&M University proposes an innovative approach. The idea? To stimulate the natural repair system of mitochondria using microscopic flower-shaped particles called « nanobloms. » The Gaharwar laboratory at Texas A&M is one of the few research groups exploring the biomedical applications of molybdenum disulfide, the inorganic compound that makes up these particles. How does it work in practice?
When introduced artificially, these nanoflowers encourage human stem cells—more specifically, mesenchymal stem cells, which are already conducive to mitochondrial transfer—to double their production of mitochondria. Akhilesh Gaharwar, PhD and researcher on the study, explains that he has succeeded in « training healthy cells to share their spare batteries with weaker cells. » By increasing the number of mitochondria inside donor cells, it becomes possible to help aging or damaged cells regain their vitality without resorting to genetic modification or traditional medication.
More effective than current drugs
The results observed are striking. Once the weakened cells received this surplus of energy, their efficiency increased « several times » and they even showed increased resistance to cell death, the process of vital functions shutting down. This breakthrough marks a promising step forward compared to existing methods, which have their share of drawbacks. For example, drugs that stimulate mitochondrial production require frequent dosing because their particles are quickly eliminated by the body. In contrast, nanoflowers persist in the cell, encouraging continuous energy production. According to the press release, the researchers anticipate that their method may only require monthly administration.
In addition, the versatility of these particles makes it possible to consider targeted treatments for various tissues, such as muscle, brain, or heart tissue. Specifically, a condition such as cardiomyopathy—a disease of the heart muscle that prevents effective blood pumping—could be treated by placing the modified cells directly in or near the heart. « We could work on this indefinitely and discover new things and new treatments every day, » enthuses John Soukar, a PhD student in genetics and genomics at Texas A&M and lead author of the study.
Towards new therapeutic strategies
Akhilesh Gaharwar sees two major clinical applications for the future. The first would involve injecting the nanoparticles directly into patients. This option would benefit people who retain some ability to replicate their mitochondria but need a boost. The second strategy, intended for patients with more severe mitochondrial problems, would involve engineering stem cells and nanoflowers outside the body before reimplantation. According to the researcher, these treatments could one day target conditions such as muscular dystrophy, neurodegenerative disorders such as Alzheimer’s disease, and other metabolic diseases where cellular energy deficiency leads to tissue degeneration.
Two months after the study was published, work is continuing actively. The team is currently conducting in vivo studies, i.e., on living organisms. Although these experiments require considerable resources, expanding animal studies remains a « major priority. » The next step will be to refine the delivery strategy to ensure that the treatment reaches the correct tissues, while gaining a better understanding of the dosage and lifespan of the nanoparticles in the body. As Gaharwar concludes, this is an early but exciting step toward recharging aging tissues via their own biological machinery, with the hope of slowing or even reversing some of the effects of cellular aging.
According to the source: popularmechanics.com
Created by humans, assisted by AI.